Doris Maribel Rivera Medina

Author

Also Known As

D.M. Rivera Medina, Doris M. Rivera Medina, Doris Maribel Rivera Medina

Publications

236

Citations

H-Index

Concepts

All Affiliations

Doris Maribel Rivera Medina is an author at GlaxoSmithKline (Belgium) specializing in vaccine efficacy, vaccine development, and vaccination.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	112
2	Vaccine Development	2	2	112
3	Epidemiology	1	1	56
4	Adolescent Primary Care	1	1	56
5	Preventive Medicine	1	1	56

Doris Maribel Rivera Medina

Publications

236

Citations

H-Index

Page 1

	Year	Citations
Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America Sri Rezeki Hadinegoro, Humberto Reynales, Mary Noreen Chua, Clinical Microbiology and Infection	2018	65
Human Rotavirus Vaccine Is Highly Efficacious When Coadministered With Routine Expanded Program of Immunization Vaccines Including Oral Poliovirus Vaccine in Latin America Miguel Tregnaghi, Héctor Abate, Alejandra Valencia, The Pediatric Infectious Disease Journal	2011	59
Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls Doris Maribel Rivera Medina, Alejandra Valencia, Alet de Velasquez, Journal of Adolescent Health VaccinationVaccine SafetyHpv-16/18 As04-adjuvanted VaccinePreventive MedicineVaccine Development	2010	56
Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years Tino F. Schwarz, Li‐Min Huang, Doris Maribel Rivera Medina, Journal of Adolescent Health VaccinationVaccine SafetyHpv-16/18 As04-adjuvanted VaccineVaccine DevelopmentHuman Papillomavirus Vaccines	2012	56

Page 1